The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
Clinical trial NCT00497146 · COMPLETED
Trial details
- NCT number
- NCT00497146
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2010-09-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.